1. Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients. (4th November 2015) Authors: Simeone, Ester; Grimaldi, Antonio Maria; Festino, Lucia; Giannarelli, Diana; Palla, Marco; Caracò, Corrado; Curvietto, Marcello; Esposito, Assunta; Paone, Miriam; Rinaldi, Giovanni; Grimaldi, Maria Chiara; Mozzillo, Nicola; Ascierto, Paolo A Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients. Issue 2 (December 2015) Authors: Simeone, Ester; Grimaldi, Antonio; Festino, Lucia; Giannarelli, Diana; Palla, Marco; Caracò, Corrado; Curvietto, Marcello; Esposito, Assunta; Paone, Miriam; Rinaldi, Giovanni; Grimaldi, Maria; Mozzillo, Nicola; Ascierto, Paolo Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients. (4th November 2015) Authors: Grimaldi, Antonio Maria; Simeone, Ester; Festino, Lucia; Giannarelli, Diana; Palla, Marco; Caracò, Corrado; Curvietto, Marcello; Esposito, Assunta; Grimaldi, Maria Chiara; Mozzillo, Nicola; Ascierto, Paolo A Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients. Issue 2 (December 2015) Authors: Grimaldi, Antonio; Simeone, Ester; Festino, Lucia; Giannarelli, Diana; Palla, Marco; Caracò, Corrado; Curvietto, Marcello; Esposito, Assunta; Grimaldi, Maria; Mozzillo, Nicola; Ascierto, Paolo Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma. (4th March 2017) Authors: Simeone, Ester; Grimaldi, Antonio Maria; Festino, Lucia; Giannarelli, Diana; Vanella, Vito; Palla, Marco; Curvietto, Marcello; Esposito, Assunta; Palmieri, Giuseppe; Mozzillo, Nicola; Ascierto, Paolo Antonio Journal: Oncoimmunology Issue: Volume 6:Number 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dermatologic adverse events associated with targeted therapies for melanoma. Issue 3 (4th March 2022) Authors: Scarpato, Luigi; Festino, Lucia; Vanella, Vito; Madonna, Gabriele; Mastroianni, Massimo; Palla, Marco; Ascierto, Paolo Antonio Journal: Expert opinion on drug safety Issue: Volume 21:Issue 3(2022) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications. (3rd April 2022) Authors: Mandel, Victor Desmond; Medri, Matelda; Manganoni, Ausilia Maria; Pavoni, Laura; De Rosa, Francesco; Ribero, Simone; Foca, Flavia; Andreis, Daniele; Mazzoni, Laura; Magi, Serena; Farnetani, Francesca; Palla, Marco; Ulivi, Paola; Stanganelli, Ignazio Journal: Journal of dermatological treatment Issue: Volume 33:Number 3(2022) Page Start: 1368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. On the origin of dust in galaxy clusters at low-to-intermediate redshift. Issue 2 (14th February 2020) Authors: Gjergo, Eda; Palla, Marco; Matteucci, Francesca; Lacchin, Elena; Biviano, Andrea; Fan, Xilong Journal: Monthly notices of the Royal Astronomical Society Issue: Volume 493:Issue 2(2020) Page Start: 2782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. Issue 2 (11th August 2020) Authors: Montesarchio, Vincenzo; Parella, Roberto; Iommelli, Chiara; Bianco, Antonella; Manzillo, Elio; Fraganza, Fiorentino; Palumbo, Cristiana; Rea, Gaetano; Murino, Patrizia; De Rosa, Rosanna; Atripaldi, Luigi; D'Abbraccio, Maurizio; Curvietto, Marcello; Mallardo, Domenico; Celentano, Egidio; Grimaldi,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. Issue 2 (11th August 2020) Authors: Montesarchio, Vincenzo; Parella, Roberto; Iommelli, Chiara; Bianco, Antonella; Manzillo, Elio; Fraganza, Fiorentino; Palumbo, Cristiana; Rea, Gaetano; Murino, Patrizia; De Rosa, Rosanna; Atripaldi, Luigi; D'Abbraccio, Maurizio; Curvietto, Marcello; Mallardo, Domenico; Celentano, Egidio; Grimaldi,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗